US FDA's devices centre urges voluntary eMDR ahead of regulation
This article was originally published in RAJ Devices
Executive Summary
The head of the US Food and Drug Administration’s devices centre is urging companies to begin voluntarily submitting adverse event reports under the electronic medical device reporting (eMDR) system. eMDR will become mandatory at some point in the future, although no set time frame has been given for this to happen.